Proposal to decrease the number of negative temporal artery biopsies

Scandinavian Journal of Rheumatology

Volumn 36, Issue 2, 2007, Pages 111-118

  Rodriguez Pla A ^a,b   Rossello Urgell J ^a   Bosch Gil, J A ^a   Huguet Redecilla, P ^a   Vilardell Tarres, M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERY DISEASE; ARTERY THICKENING; ARTICLE; BLOOD VESSEL BIOPSY; CLAUDICATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HUMAN; JAW; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PULSE RATE; RISK; SCALP TENDERNESS; TEMPORAL ARTERY; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; BIOPSY; BLOOD SEDIMENTATION; CROSS-SECTIONAL STUDIES; FEMALE; HEADACHE; HUMANS; JAW DISEASES; LIKELIHOOD FUNCTIONS; MALE; ODDS RATIO; PAIN; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 34247640145     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600991646     Document Type: Article

References (23)

1. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990;33:1074-87.
2. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51:504-10.
3. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? J Am Med Assoc 2002;287:1528-9.
4. Lenton J, Donnelly R, Nash JR. Does temporal artery biopsy influence the management of temporal arteritis? Q J Med 2006;99:33-6.
5. Bhatti MT, Goldstein MH. Facial nerve injury following superficial temporal artery biopsy. Dermatol Surg 2001;27:15-7.
6. Hall S, Hunder GG. Is temporal artery biopsy prudent? Mayo Clin Proc 1984;59:793-6.
7. Hedges TR 3rd, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 1983;101:1251-4.
8. Ikard RW. Clinical efficacy of temporal artery biopsy in Nashville, Tennessee. South Med J 1988;81:1222-4.
9. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. Arthritis Rheum 1998;41:1960-5.
10. Le Page L, Duhaut P, Seydoux D, Bosshard S, Ecochard R, Abbas F, et al. [Incidence of cardiovascular events in giant cell arteritis: preliminary results of a prospective double cohort study (GRACG)], in French. Rev Med Interne 2006;27:98-105.
11. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
12. Gabriel SE, O'Fallon WM, Achkar AA, Lie JT, Hunder GG. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995;22:93-6.
13. Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005;32:1279-82.
14. McDonnell PJ, Moore GW, Miller NR, Hutchins GM, Green WR. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986;93:518-30.
15. Varma D, O'Neill D. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis. Eye 2004;18:384-8.
16. Vilaseca J, Gonzalez A, Cid MC, Lopez-Vivancos J, Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis 1987;46:282-5.
17. Younge BR, Cook BE Jr, Bartley GB, Hodge DO, Hunder GG. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc 2004;79:483-91.
18. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
19. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001;30:249-56.
20. Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Arterite a Cellules Geantes. Ann Rheum Dis 1999;58:335-41.
21. Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 2005;34:284-92.
22. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285.
23. Brun JG, Madland TM, Gran JT, Myklebust G. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity. Scand J Rheumatol 2005;34:125.